Chemotherapy-induced peripheral neuropathy (CIPN) is the most common off-target
adverse effects caused by various chemotherapeutic agents, such as cisplatin, oxaliplatin …

Chemotherapeutic agents cause many short and long term toxic side effects to peripheral
nervous system (PNS) that drastically alter quality of life. Chemotherapy-induced peripheral …

Many anti-cancer drugs, such as taxanes, platinum compounds, vinca alkaloids, and
proteasome inhibitors, can cause chemotherapy-induced peripheral neuropathy (CIPN) …

Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of typical
chemotherapeutics among cancer survivors. Despite the recent progress, the effective …

Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse effect caused by
several classes of widely used anticancer therapeutics. Chemotherapy-induced peripheral …

Chemotherapy-induced peripheral neuropathy (CIPN) is a common, debilitating, and dose-
limiting side effect of many chemotherapy regimens yet has limited treatments due to …

Chemotherapy-induced peripheral neuropathy (CIPN) is a serious and often persistent
adverse consequence of certain chemotherapeutic agents. It is a major dose-limiting factor …

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a progressive,
enduring, and often irreversible adverse effect of many antineoplastic agents, among which …

Neurotoxic anticancer drugs, such as platinum-based anticancer drugs, taxanes, vinca
alkaloids, and proteasome/angiogenesis inhibitors are responsible for chemotherapy …

Chemotherapy-induced peripheral neuropathy (CIPN) is a major long-lasting side effect of
some chemotherapy drugs, which threatens cancer survival rate. CIPN mostly affects …